Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 25,000 shares at $30.06 ($751K) on 2016-05-27, disclosed to the SEC on 2016-06-01.
Scheduled sale ($751k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.06 | 5,280 | $159K | 21.1% |
| 2 | $30.05 | 19,720 | $593K | 78.9% |
| Total | $30.05 avg | 25,000 | $751K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |